Corpus Intelligence IC Memo — MH-LAKESHORE CAMPUS 2026-04-27 04:13 UTC
IC Memo — MH-LAKESHORE CAMPUS
Investment Committee Memorandum | MI | 24 beds | Grade C | EBITDA uplift $3.1M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 231320

MH-LAKESHORE CAMPUS

LOCATIONOCEANA, MI·BEDS24·AS OFApril 27, 2026
C
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

MH-LAKESHORE CAMPUS is a 24-bed suburban community hospital in OCEANA, MI with $41.9M in net patient revenue and a 12.3% operating margin. The hospital serves a payer mix of 32.0% Medicare, 2.3% Medicaid, and 65.7% commercial.

Thesis: Turnaround. Our ML models identify $3.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.3% to 19.7% (+736bps).

Net Revenue HCRIS$41.9M
Current EBITDA COMPUTED$5.2M
Operating Margin COMPUTED12.3%
Occupancy HCRIS12.4%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS49.3%
Distress Probability ML57.6%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
67
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of 12.3% places it above the state median. Among 67 size-comparable peers (12-48 beds), the median margin is -3.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-48), prioritizing same-state peers. 67 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MH-LAKESHORE CAMPUS (Target)MI24$41.9M12.3%
TRINITY HEALTH LIVINGSTONMI42$200.4M15.2%
SPECTRUM HEALTH UNITED MEMORIAMI45$129.4M9.7%
SPECTRUM HEALTH GERBERMI25$116.2M16.0%
SPECTRUM HEALTH LUDINGTONMI45$110.1M5.3%
OTSEGO MEMORIAL HOSPITALMI46$109.4M-3.2%
ST. FRANCIS HOSPITALMI25$106.2M7.8%
SPECTRUM HEALTH PENNOCK HOSPITMI25$96.5M11.1%
MUNSON HEALTHCARE GRAYLING HOSMI42$87.2M-10.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$879K+210bp18mo
Cost to Collect4.5%2.5%$838K+200bp12mo
Denial Rate Reduction12.0%6.5%$829K+198bp12mo
A/R Days Reduction5200.0%3800.0%$510K+122bp9mo
Clean Claim Rate88.0%96.0%$27K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$879K
Cost to Collect
$838K
Denial Rate Reduction
$829K
A/R Days Reduction
$510K
Clean Claim Rate
$27K
Total EBITDA Uplift$3.1M
Current EBITDA$5.2M
+ RCM Uplift+$3.1M
Pro Forma EBITDA$8.2M
Current Margin12.3%
Pro Forma Margin19.7%
WC Released (1x)$1.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$7.9M$64.8M8.17x52.2%
Base (11x exit)10.0x11.0x$7.9M$73.9M9.32x56.3%
Bull Case9.0x11.0x$7.1M$86.6M12.14x64.8%
Bull (12x exit)9.0x12.0x$7.1M$96.6M13.54x68.4%
Bear Case11.0x10.0x$8.7M$46.8M5.37x40.0%
Bear (11x exit)11.0x11.0x$8.7M$54.4M6.23x44.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 12.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 67 hospitals with 12-48 beds
  • Same-state prioritization (n=68)
  • Comp margins: P25=-11.3% / P50=-3.4% / P75=8.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.